Key words: combined liver/kidney transplantation; reference range of 20-40 mmol/l. Prior to analysis, an nephrocalcinosis; primary hyperoxaluria ultrafiltration of plasma to remove proteins and others molecules was performed. Urine ion chromatography was used for measuring urine oxalate concentration with a reference range of
Introduction 100-450 mmol/24 h. Calcium oxalate deposition in the tissue was identified by means of a polarized light Primary hyperoxaluria type I (PHI ) is a rare disorder technique. due to a deficiency or mistargeting (mitochondrial ) of peroxisomal alanine5glyoxylate aminotransferase (AGT ) in the liver cells [1] . The subsequent failure of Case report amination of glyoxylate leads to oxidation of excessive amounts of glyoxylate to oxalate. Glycolate forms a A 53-year-old female was admitted in 1984 for further soluble calcium salt and is readily excreted in the urine. management of ESRD. A diagnosis of PHI was made Calcium oxalate has a very low solubility leading to on the basis of bilateral nephrocalcinosis, recurrent nephrocalcinosis, urolithiasis, and progressive renal nephrolithiasis, markedly elevated plasma oxalate coninsufficiency. Once renal function declines, oxalate centration (99.75 mmol/l, normal range 20-40 mmol/l ), which is only excreted by the kidney, accumulates and calcium oxalate deposits ( Figure 1a ) in skin, vessels, calcium oxalate gets deposited in various tissues-a marrow, and liver. Indeed, the liver and marrow biopscondition called 'systemic oxalosis'. In case of PHI, ies showed a chronic granulomatous inflammation in renal replacement therapy treatment by haemodialysis response to calcium oxalate deposition. Peroxisomal or isolated renal transplantation give poor results. AGT activity in hepatocytes was determined and was Haemodialysis cannot achieve an oxalate removal rate absent. Despite intensive haemodialysis (6 h three times equal to endogenous production rate and systemic per week with a high permeability membrane), systemic oxalosis will progressively worsen. Isolated renal trans-oxalosis worsened. A combined liver-kidney transplantation will invariably result in rapid recurrence plantation was performed in 1990 with vigorous preand destruction of the graft unless the enzyme defi-and postoperative haemodialysis. Postoperatively urine ciency is partial [2] . Thus, combined liver/kidney trans-output was maintained in a range of 500 ml/h. plantation or even isolated liver transplantation before Immunosuppression included steroids, azathioprine, the patient reaches end-stage renal disease ( ESRD) cyclosporine and thymoglobulin (IMTIX, Lyon, seems the best approach [3] [4] [5] [6] . However, the presence France) and the patient received crystallization inhibof massive oxalate tissue deposits may destroy the itors. She was discharged with stable renal (serum transplanted kidney, even after enzyme replacement creatinine 80 mmol/l ) and hepatic function but with therapy. We report a case where recurrence of nephrohigh plasma (52.44 mmol/l ) and urine (1824 mmol/24 h) calcinosis in the graft led to ESRD 6 years after a oxalate concentrations. These concentrations remained combined liver/kidney transplantation and was suchigh despite normal renal function for the first 2 years. cessfully treated by a second renal transplant.
The renal function progressively declined over the next 4 years due to recurrent nephrocalcinosis. Seventy-
Methodologies for analysis of oxalate
seven months after transplantation, haemodialysis was resumed on a daily basis until a second isolated renal Plasma oxalate concentration was carried out by means transplantation was performed three weeks later on of a soluble oxalate oxidase assay (BioRea kit) with a December 1996. Postoperative haemodialysis was started daily and then every other day; urine output serum creatinine was 66 mmol/l, plasma oxalate renal transplantation will excrete oxalate released from tissue stores. In 1987, Watts et al. reported a successful 47 mmol/l and 24 h urine oxalate 1612 mmol/24 h. A hand X-ray taken on day 79 showed significant reso-combined liver-kidney transplantation [10] . The European PHI transplant registry reported the results lution of soft tissue calcification ( Figure 1b) . Eleven months after transplantation, serum creatinine was of 64 liver transplants in 61 patients (58 kidney-liver, three isolated liver, three liver retransplantation). The 70 mmol/l, plasma (13 mmol/l ) and urine (1170 mmol/l ) oxalate were within the normal range.
1-year actuarial patient and graft survival rate was 88% [11] and the 5-year patient survival rate was 80%. Timing of the combined transplantation is import-
Discussion
ant. The longer the period from onset of end-stage renal disease, the greater the risk of recurrence of nephrocalcinosis over the years (despite correction of The risk of recurrence is of major concern in patients the metabolic defect). Our patient developed ESRD in with ESRD due to PHI. A report from the EDTA 1984 and was on dialysis for 6 years before a combined Registry in 1990 showed an overall 1-year graft survival liver-kidney transplantation was performed. She had rate of 26% in 79 PHI patients with first cadaveric clear evidence of severe systemic oxalosis with calcium renal allografts [7] . This data must be carefully anaoxalate crystal deposits in skin, vessels, bone marrow, lysed since it includes patients who have been transand liver. After transplantation, despite the correction planted years before 1990.
of the metabolic defect, she continued to have high Scheinman et al. [8] proposed a specific strategy plasma oxalate concentration due to tissue release, adapted to isolated kidney transplantation. They leading to high urine oxalate excretion and to subrecommended intensive pretransplant dialysis, the use sequent recurrence of nephrocalcinosis in the graft. of living related donors, antilymphocyte globulin, high However, this first kidney graft achieved partial tissue urine volume, and inhibitors of crystal growth. Of 10 oxalate depletion, allowing a second transplant to be live related donor transplants treated by such a stratperformed. egy, seven had a good renal function beyond the first In summary, this case highlights the fact that comyear. However the longterm outcome was poor [9] bined liver-kidney transplantation should be performed because of rapid recurrence of nephrocalcinosis due to even in those patients presenting for the first time with persistent oxalate overproduction and release of oxal-ESRD and systemic oxalosis. In such conditions, recurate from tissue stores.
rence takes a long time and if needed a second renal Simultaneous liver-kidney transplantation will transplant can be performed. The second graft will reduce the risk of recurrence. Liver transplantation will stop oxalate overproduction and simultaneous have a much lower risk of recurrence because of the primary hyperoxaluria type I: the European experience. Nephrol depletion of the oxalate pool achieved by the first Dial Transplant 1992; 6: 502-511 renal graft.
5. Cochat P, Mahmoud A. Transplantation in primary hyperoxaluMoreover, some authors [10] suggest pre-emptive or ria type 1. Nephrol Dial Transplant 1995; 10: 1293 -1296 early combined liver-kidney transplantation, avoiding 
